Just out in @jtoonline.bsky.social !

First-line treatment with #BRAF/#MEK targeted therapy or with (chemo)-immunotherapy results in similar survival outcomes in #BRAF-V600 mutated #NSCLC patients.
#LCSM

www.jto.org/article/S155...

Quick shout-out on these two collaborative networks (#BOLERO
and #COALA) during my presentation at #ELCC25.

Looking forward to advancing basic and translational research on #BRAF-mutant #NSCLC and other oncogene-driven #NSCLC.

x.com/JulienMazier...

Three days of great science at the #EACR meeting on #persister cells. We presented our work on models of therapy-residual disease in #BRAF-mutant lung cancer.
Great to have part of the #COALA and #BOLERO crowds in Lyon !

@helloeacr.bsky.social
@ocalvayrac.bsky.social
@maraverlab.bsky.social

Impressive talk by Lise Mangiante
on tissue ecology from ER+ breast cancer. #CRCL25
www.nature.com/articles/s41...

Great kick-off of the #CRCL25 symposium with a keynote lecture by Joan Massague, on metastasis initiation.
www.crclsymposium2025.fr/en/program/d...